$367.97
9.042.52%
At close: -
$367.97
0.000.00%
After Hours: 4:00 PM EDT
United Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-30 | $6.39 | $6.42 | -0.47 % |
Q2 | 2024-07-31 | $5.85 | $6.40 | -8.59 % |
Q1 | 2024-05-01 | $6.17 | $5.65 | 9.20 % |
Q4 | 2024-02-21 | $4.36 | $4.19 | 4.06 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-30 | $748.90M | $722.58M | 3.64 % |
Q2 | 2024-07-31 | $714.90M | $691.87M | 3.33 % |
Q1 | 2024-05-01 | $677.70M | $623.97M | 8.61 % |
Q4 | 2024-02-21 | $614.70M | $575.87M | 6.74 % |
United Therapeutics (UTHR) is scheduled to report earnings on February 19, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $6.39, which missed the estimate of $6.42.
The Actual Revenue was $748.9M, which beat the estimate of $722.6M.
Browse earnings estimates, EPS, and revenue on all stocks.